PRASANTI TATINI: Open Payments
NPI 1942403183 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,074 in 194 payments from 15 companies in 2025. Trend: 2023 $2,415 · 2024 $2,997 · 2025 $3,074
Food & beverage: $3,068Education: $6
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $431 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 24 | $422 |
| Vanda Pharmaceuticals Inc. | 22 | $327 |
| Otsuka America Pharmaceutical, Inc. | 18 | $313 |
| Alkermes, Inc. | 20 | $308 |
| Lundbeck LLC | 13 | $241 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $226 |
| Neurocrine BioSciences, Inc. | 11 | $197 |
| E.R. Squibb & Sons, L.L.C. | 13 | $190 |
| Almatica Pharma LLC | 13 | $164 |
Products named: REXULTI, VRAYLAR, CAPLYTA, FANAPT, TRINTELLIX, INGREZZA, COBENFY, LYBALVI.
Industry payments across FL — which companies pay providers there.
